• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody.

作者信息

Wang Jing Jing, Armour Bridie, Chataway Tim, Troelnikov Alexander, Colella Alex, Yacoub Olivia, Hockley Simon, Tan Chee Wee, Gordon Tom Paul

机构信息

Department of Immunology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.

Department of Immunology, South Australia (SA) Pathology (Flinders Medical Centre), Bedford Park, SA, Australia.

出版信息

Blood. 2022 Oct 13;140(15):1738-1742. doi: 10.1182/blood.2022016474.

DOI:10.1182/blood.2022016474
PMID:35661872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9906116/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35b/9906116/90709385c343/BLOOD_BLD-2022-016474-gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35b/9906116/d230d9968712/BLOOD_BLD-2022-016474-fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35b/9906116/90709385c343/BLOOD_BLD-2022-016474-gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35b/9906116/d230d9968712/BLOOD_BLD-2022-016474-fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35b/9906116/90709385c343/BLOOD_BLD-2022-016474-gr1_lrg.jpg

相似文献

1
Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody.疫苗诱导的免疫性血栓性血小板减少症由一种刻板的克隆型抗体介导。
Blood. 2022 Oct 13;140(15):1738-1742. doi: 10.1182/blood.2022016474.
2
The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症的起伏变化
Lancet Haematol. 2022 Apr;9(4):e246. doi: 10.1016/S2352-3026(22)00078-3.
3
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins.肝素诱导的血小板减少症与疫苗诱导的免疫性血栓性血小板减少症抗体：异卵而非同卵双胞胎。
Thromb Haemost. 2021 Dec;121(12):1558-1561. doi: 10.1055/a-1585-6264. Epub 2021 Sep 23.
4
Vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症。
Blood. 2023 Apr 6;141(14):1659-1665. doi: 10.1182/blood.2022017696.
5
COVID vaccine-induced immune thrombotic thrombocytopenia: Rare but relevant.新冠疫苗诱导的免疫性血栓性血小板减少症：罕见但值得关注。
Eur J Intern Med. 2022 Nov;105:20-22. doi: 10.1016/j.ejim.2022.09.012. Epub 2022 Sep 17.
6
Vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）。
Semin Hematol. 2022 Apr;59(2):57-58. doi: 10.1053/j.seminhematol.2022.03.004. Epub 2022 Mar 8.
7
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia.用于ChAdOx1 nCov-19疫苗诱导的免疫性血栓性血小板减少症的双倍高剂量免疫球蛋白
Thromb Res. 2021 Oct;206:14-17. doi: 10.1016/j.thromres.2021.07.017. Epub 2021 Aug 4.
8
"Vaccine-induced immune thrombotic thrombocytopenia (VITT)-Update on diagnosis and management considering different resources": Comment.“疫苗诱导的免疫性血栓性血小板减少症（VITT）——考虑不同资源的诊断和管理最新进展”：评论
J Thromb Haemost. 2022 Nov;20(11):2707-2708. doi: 10.1111/jth.15853.
9
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症所致的大面积脑静脉血栓形成
Haematologica. 2021 Nov 1;106(11):3021-3024. doi: 10.3324/haematol.2021.279246.
10
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report.国药（HB02）疫苗相关免疫性血栓性血小板减少症：一例报告。
J Med Case Rep. 2023 Sep 8;17(1):383. doi: 10.1186/s13256-023-04086-7.

引用本文的文献

1
VITT Pathophysiology: An Update.疫苗诱导的血栓性血小板减少症（VITT）的病理生理学：最新进展
Vaccines (Basel). 2025 Jun 17;13(6):650. doi: 10.3390/vaccines13060650.
2
Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.抗PF4介导的血小板减少症和与急性巨细胞病毒感染相关的血栓形成表现出类似肝素诱导的血小板减少症（HIT）和疫苗诱导的免疫性血小板减少症（VITT）的特征。
Br J Haematol. 2025 Jun;206(6):1737-1742. doi: 10.1111/bjh.20092. Epub 2025 Apr 29.
3
Anti-Platelet factor 4 immunothrombosis-not just heparin and vaccine triggers.

本文引用的文献

1
Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.单克隆和寡克隆抗血小板因子 4 抗体介导 VITT。
Blood. 2022 Jul 7;140(1):73-77. doi: 10.1182/blood.2021014588.
2
Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的发病机制。
Semin Hematol. 2022 Apr;59(2):97-107. doi: 10.1053/j.seminhematol.2022.02.004. Epub 2022 Feb 23.
3
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S.接种Ad26.COV2.S疫苗的患者中疫苗诱导的血栓性血小板减少症（VITT）抗体的特征
抗血小板因子4免疫性血栓形成——不仅仅是肝素和疫苗引发的。
Res Pract Thromb Haemost. 2025 Mar 12;9(2):102729. doi: 10.1016/j.rpth.2025.102729. eCollection 2025 Feb.
4
Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT.源自疫苗诱导的免疫性血小板减少症和血栓形成（VITT）患者的重组抗PF4抗体有助于VITT的研究和实验室诊断。
Vaccines (Basel). 2024 Dec 24;13(1):3. doi: 10.3390/vaccines13010003.
5
Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis.血小板脾酪氨酸激酶是抗PF4抗体诱导的免疫血栓形成的关键调节因子。
Blood Adv. 2025 Apr 22;9(8):1772-1785. doi: 10.1182/bloodadvances.2024014167.
6
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.针对重症 COVID-19 中刺突蛋白受体结合域的促血栓形成抗体。
Blood. 2025 Feb 6;145(6):635-647. doi: 10.1182/blood.2024025010.
7
Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症的遗传易感性。
Br J Haematol. 2025 Jan;206(1):387-388. doi: 10.1111/bjh.19885. Epub 2024 Nov 10.
8
Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments.疫苗诱导的免疫性血栓性血小板减少症治疗的抗栓疗效和出血风险。
Blood Adv. 2024 Nov 26;8(22):5744-5752. doi: 10.1182/bloodadvances.2024013883.
9
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.报告的 COVID-19 疫苗接种后主要严重不良事件的发生率和处理。
Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224.
10
Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders.疫苗诱导的免疫性血栓性血小板减少症：抗PF4抗体介导疾病的临床病理特征及新观点
J Clin Med. 2024 Feb 9;13(4):1012. doi: 10.3390/jcm13041012.
Blood Adv. 2023 Jan 24;7(2):246-250. doi: 10.1182/bloodadvances.2022007336.
4
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome.ChAdOx1与CAR和PF4相互作用，对伴有血小板减少的血栓形成综合征有影响。
Sci Adv. 2021 Dec 3;7(49):eabl8213. doi: 10.1126/sciadv.abl8213. Epub 2021 Dec 1.
5
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.腺病毒载体新冠疫苗诱导的免疫性血栓性血小板减少症的相关认识。
Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.
6
Decline in Pathogenic Antibodies over Time in VITT.疫苗诱导的血栓性血小板减少症（VITT）中致病性抗体随时间的下降
N Engl J Med. 2021 Nov 4;385(19):1815-1816. doi: 10.1056/NEJMc2112760. Epub 2021 Sep 8.
7
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.抗血小板因子 4 抗体导致的 VITT 与 SARS-CoV-2 刺突蛋白不发生交叉反应。
Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938.
8
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.疫苗诱导免疫性血栓性血小板减少症的抗体表位。
Nature. 2021 Aug;596(7873):565-569. doi: 10.1038/s41586-021-03744-4. Epub 2021 Jul 7.
9
Case Report: Thrombotic Thrombocytopenia after COVID-19 Janssen Vaccination.病例报告：新冠病毒杨森疫苗接种后发生血栓性血小板减少症
Am Fam Physician. 2021 Jun 1;103(11):646-647.
10
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.接种 ChAdOx1 nCoV-19 疫苗后对血小板因子 4 的病理性抗体。
N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16.